Traws Pharma Inc. (TRAW)
NASDAQ · Healthcare
Traws Pharma Inc. Shareholder Equity 2011–2025
Traws Pharma Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Traws Pharma Inc. shareholder equity as of December 31, 2025: -629,000, a 98.01% decrease year-over-year.
- Traws Pharma Inc. shareholder equity for 2025 were -629,000, a 98.01% decrease from 2024.
- Traws Pharma Inc. shareholder equity for 2024 were -31.6M, a 396.38% decrease from 2023.
- Traws Pharma Inc. shareholder equity for 2023 were 10.7M, a 62.30% decrease from 2022.
- Traws Pharma Inc. shareholder equity for 2022 were 28.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Traws Pharma Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-1 |
| 2024 | $-32 |
| 2023 | $11 |
| 2022 | $28 |
| 2021 | $46 |
| 2020 | $6 |
| 2019 | $12 |
| 2018 | $5 |
| 2017 | $-12 |
| 2016 | $4 |
| 2015 | $10 |
| 2014 | $23 |
| 2013 | $80 |
| 2012 | $-158 |
Traws Pharma Inc. Shareholder Equity — FAQ
Traws Pharma Inc. (TRAW) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TRAW's shareholder equity history?
The chart and table above show Traws Pharma Inc.'s shareholder equity by year and by quarter, including the growth rate.